31 – 40 of 74
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men.
(
- Contribution to journal › Article
-
Mark
Procedural Volume and Outcomes With Radial or Femoral Access for Coronary Angiography and Intervention
(
- Contribution to journal › Article
-
Mark
Stent Thrombosis in New-Generation Drug-Eluting Stents in Patients With STEMI Undergoing Primary PCI: A Report From SCAAR.
(
- Contribution to journal › Article
-
Mark
Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the malmö diet and cancer study.
(
- Contribution to journal › Article
-
Mark
Predictors of early postoperative complications after arterial switch operation of newborns with transposition of the great arteries
2014) American College of Cardiology 2014 In Journal of the American College of Cardiology 63(12, Suppl 1). p.584-584(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: The GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
(
- Contribution to journal › Article
-
Mark
Population Trends in Percutaneous Coronary Intervention 20-Year Results From the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)
(
- Contribution to journal › Article
- 2012
-
Mark
In Silico Cardiac Risk Assessment in Patients With Long QT Syndrome Type 1: Clinical Predictability of Cardiac Models
(
- Contribution to journal › Article
-
Mark
Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients: Results From the FEATHER Trial.
(
- Contribution to journal › Article
-
Mark
Impact of QRS Duration and Morphology on the Risk of Sudden Cardiac Death in Asymptomatic Patients With Aortic Stenosis The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
(
- Contribution to journal › Article